4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-22-000041
EVP, Chief Strat & Dev Officer gave up 764 shares (to pay taxes)
- EVP, Chief Strat & Dev Officer acquired 48,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SARAN ATUL EVP, Chief Strat & Dev Officer | 2022-03-01 | Grant or award | +31,417 | 74,630 | D: show line 1 in the form | ||
| SARAN ATUL EVP, Chief Strat & Dev Officer | 2022-03-01 | Grant or award | +16,916 | 91,546 | D: show line 2 in the form | ||
| SARAN ATUL EVP, Chief Strat & Dev Officer | 2022-02-28 | Shares withheld for taxes | −764 | $39.64 | $30,285 | 90,782 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| SARAN ATUL EVP, Chief Strat & Dev Officer | 2022-03-01 | Grant or award · Employee Stock Options (Right to Buy) | +38,664 | $41.38 | $1,599,916 | 38,664 | D: show line 4 in the form |
Loading xslF345X03/wf-form4_164626470277626.xml…